02 September 2022 | NewsVideo now available | NCIRS webinar - Emerging vaccine preventable diseases and vaccination for travelRead the full article
How do we get to immunisation business as usual while living with SARS-CoV-2?
The first NCIRS webinar for 2022 aks where we are and where we are headed as we move into the third year of the COVID-19 pandemic. Watch to hear from our expert speakers on:
Professor Kristine Macartney
Director - NCIRS
Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of the University of NSW and has over 20 years of experience in vaccinology. She has experience working in the USA at the Children’s Hospital of Philadelphia where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates.
She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. She is the Senior Editor of the Australian Immunisation Handbook. Kristine is a Staff Specialist in Infectious Diseases and Microbiology at The Children’s Hospital at Westmead and has a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health, University of Sydney.
Associate Professor Nigel Crawford
Director, Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) - Murdoch Children’s Research Institute. Head, Immunisation Services - Royal Children’s Hospital, Melbourne
Associate Professor Nigel Crawford is a General Paediatrician and Medical Head of Immunisation Services at The Royal Children's Hospital, Melbourne. He is also Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), a national vaccine safety and clinical immunisation research group based at the Murdoch Children’s Research Institute, as well as the Melbourne Vaccine Education Centre.
Associate Professor Crawford has a research interest in vaccine safety, special risk groups and immunisation policy. He has been a member of the Australian Technical and Advisory Group on Immunisation (ATAGI) since 2014 and is the current Chair. He is also a member of the Australian Regional Immunisation Alliance (ARIA).
Professor Katie Flanagan
Australian Technical Advisory Group on Immunisation (ATAGI), Head of Infectious Diseases, Launceston General Hospital
Katie Flanagan is a clinician scientist who has worked on global health issues for more than 25 years. She has led numerous vaccine immunology trials throughout the world. She has been a member of the Australian Technical Advisory Group on Immunisation (ATAGI) since 2019 and is currently co-lead of the ATAGI COVID-19 Working Group.